FDA Approved: ENTECAVIR — Supplemental Application (Zydus Lifesciences Limited)

View source ↗

Summary

FDA approved a supplemental application to allow Zydus Lifesciences Limited to market a generic entecavir (ENTECAVIR) in the United States.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• ENTECAVIR (ENTECAVIR)

Snippet

SUPPL AP for ENTECAVIR (ENTECAVIR)